Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A generalized F mixture model for cure rate estimation

Y Peng1, K B Dear, J W Denham

  • 1Department of Statistics, University of Newcastle, NSW, Australia. peng@frey.newcastle.edu.au

Statistics in Medicine
|May 22, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial.

Pathology·2021
Same author

Radiotherapy dose-distribution to the perirectal fat space (PRS) is related to gastrointestinal control-related complications.

Clinical and translational radiation oncology·2018
Same author

Is body mass index associated with lowest mortality increasing over time?

International journal of obesity (2005)·2017
Same author

Gene structure and expression characteristic of a novel odorant receptor gene cluster in the parasitoid wasp Microplitis mediator (Hymenoptera: Braconidae).

Insect molecular biology·2017
Same author

Inhibition of DNA2 nuclease as a therapeutic strategy targeting replication stress in cancer cells.

Oncogenesis·2017
Same author

Increased GLP2R expression in gastric chief cells of patients with severe obesity regardless of diabetes status.

International journal of obesity (2005)·2017
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
See all related articles

This study introduces a flexible generalized F mixture model for cure rate estimation in clinical trials. This advanced statistical method improves robustness and uncovers hidden data structures in diseases like lymphoma.

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology
  • Cancer Research

Background:

  • Cure rate estimation is crucial in clinical trials for diseases like lymphoma and breast cancer.
  • Mixture models are standard statistical methods, but often rely on strong distributional assumptions.
  • Existing models may lack robustness to deviations from these assumptions.

Purpose of the Study:

  • To propose a novel mixture model using the generalized F distribution family for enhanced cure rate estimation.
  • To relax restrictive distributional assumptions inherent in traditional mixture models.
  • To improve the ability to detect complex data structures in clinical trial data.

Main Methods:

  • Development of a mixture model based on the generalized F distribution family.

Related Experiment Videos

  • Application of the model to large-scale clinical trial data from lymphoma patients.
  • Discussion of computational challenges and model selection techniques.

    • Main Results:

    • The generalized F mixture model demonstrates high flexibility, encompassing common distributions as special cases.
    • The model successfully relaxed traditional distributional assumptions, revealing previously undetected data patterns.
    • Fitting the model to lymphoma trial data illustrated its practical utility.

    Conclusions:

    • The generalized F mixture model offers a more robust and flexible approach to cure rate estimation in clinical trials.
    • This methodology can enhance the analysis of complex survival data, particularly in oncology.
    • Further research into computational aspects and model selection is warranted.